(Q43518009)

24 November 2017

Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla (English)

1 reference

24 November 2017

1 reference

Heinricher MM

1

1 reference

24 November 2017

McGaraughty S

series ordinal

2

1 reference

24 November 2017

Tortorici V

series ordinal

3

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Journal of Neurophysiology

24 November 2017

1 reference

24 November 2017

85

1 reference

24 November 2017

1

1 reference

24 November 2017

280-286

1 reference

Cholecystokinin-induced activity changes of dorsal lateral geniculate neurons in rats.

24 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Putative pain modulating neurons in the rostral ventral medulla: reflex-related activity predicts effects of morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Putative nociceptive modulatory neurons in the rostral ventromedial medulla of the rat display highly correlated firing patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Endogenous Pain Control Systems: Brainstem Spinal Pathways and Endorphin Circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Hyperalgesia during naloxone-precipitated withdrawal from morphine is associated with increased on-cell activity in the rostral ventromedial medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Ionic mechanisms underlying cholecystokinin action in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

CCK(B) receptors in the periaqueductal grey are involved in electroacupuncture antinociception in the rat cold water tail-flick test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cholecystokinin-dopamine interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Neurotransmitters in Nociceptive Modulatory Circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Evidence that disinhibition of brain stem neurones contributes to morphine analgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Stress reduces morphine's antinociceptive potency: dependence upon spinal cholecystokinin processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

The role of excitatory amino acid transmission within the rostral ventromedial medulla in the antinociceptive actions of systemically administered morphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Circuitry underlying antiopioid actions of orphanin FQ in the rostral ventromedial medulla.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Direct and indirect actions of morphine on medullary neurons that modulate nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Disinhibition of off-cells and antinociception produced by an opioid action within the rostral ventromedial medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Interference with GABA transmission in the rostral ventromedial medulla: disinhibition of off-cells as a central mechanism in nociceptive modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Highly delta selective antagonists in the RVM attenuate the antinociceptive effect of PAG DAMGO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Supraspinal cholecystokinin may drive tonic descending facilitation mechanisms to maintain neuropathic pain in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Characterization of the effect of cholecystokinin (CCK) on neurons in the periaqueductal gray of the rat: immunocytochemical and in vivo and in vitro electrophysiological studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Inhibition of morphine withdrawal by the association of RB 101, an inhibitor of enkephalin catabolism, and the CCKB antagonist PD-134,308

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

A locus and mechanism of action for associative morphine tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Modulation of opioid antinociception by CCK at the supraspinal level: evidence of regulatory mechanisms between CCK and enkephalin systems in the control of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Naltrindole, an opioid delta antagonist, blocks the enhancement of morphine-antinociception induced by a CCKB antagonist in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

A cellular mechanism for the bidirectional pain-modulating actions of orphanin FQ/nociceptin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Reversible inactivation of raphe magnus neurons: effects on nociceptive threshold and morphine-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Molecular forms of cholecystokinin in the brain and the relationship to neuronal gastrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cholecystokinin and enkephalin in brain stem pain modulating circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cholecystokinin and morphine analgesia: variations on a theme

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cholecystokinin antagonists selectively potentiate analgesia induced by endogenous opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cholecystokinin antianalgesia: safety cues abolish morphine analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

The nature of conditioned anti-analgesia: spinal cord opiate and anti-opiate neurochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Cholecystokinin/opioid interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Studies on the antagonism by raphe lesions of the antinociceptive action of systemic morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FJN.2001.85.1.280

release_symfsjf6gvf47chogwsrppxspe

21 January 2018

Identifiers

DOI

10.1152/JN.2001.85.1.280

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/symfsjf6gvf47chogwsrppxspe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference